Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
于乐发布了新的文献求助10
刚刚
dj920616发布了新的文献求助30
1秒前
2秒前
文艺雁兰发布了新的文献求助10
3秒前
111驳回了丘比特应助
4秒前
所所应助linman采纳,获得10
5秒前
5秒前
CodeCraft应助恋人采纳,获得10
7秒前
希妍发布了新的文献求助10
8秒前
yaya125完成签到 ,获得积分10
9秒前
顾矜应助多喝水采纳,获得10
9秒前
哞哞哞发布了新的文献求助10
10秒前
刘旦生发布了新的文献求助10
10秒前
zho应助陶醉代云采纳,获得10
10秒前
陈光华发布了新的文献求助10
12秒前
12秒前
今天完成签到,获得积分10
13秒前
13秒前
MXS关注了科研通微信公众号
14秒前
汉堡包应助kangk采纳,获得10
15秒前
Abel完成签到,获得积分10
16秒前
17秒前
aaa发布了新的文献求助10
18秒前
着急的迎蕾完成签到,获得积分20
18秒前
Clytze发布了新的文献求助10
19秒前
20秒前
20秒前
不许人间见白头完成签到 ,获得积分20
20秒前
21秒前
wjj完成签到,获得积分10
21秒前
bobochicken完成签到,获得积分10
21秒前
张艳茹发布了新的文献求助10
22秒前
刘旦生完成签到,获得积分10
22秒前
zm完成签到,获得积分10
22秒前
FashionBoy应助linman采纳,获得10
22秒前
情怀应助Abel采纳,获得10
23秒前
小陈陈完成签到,获得积分20
23秒前
Dillen发布了新的文献求助10
23秒前
zzz发布了新的文献求助10
23秒前
kkkkkkkkkkk发布了新的文献求助10
25秒前
高分求助中
Principles of Economics, 11th Edition 10000
Prescott's Microbiology: 2026 Release ISE 10000
University Physics with Modern Physics, 16th edition 10000
Cronologia da história de Macau 5000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Interactions of Vowel Quality and Prosody in East Slavic 1000
Matrix Methods in Data Mining and Pattern Recognition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7156186
求助须知:如何正确求助?哪些是违规求助? 8800762
关于积分的说明 18598944
捐赠科研通 6756934
什么是DOI,文献DOI怎么找? 3161429
关于科研通互助平台的介绍 2296074
邀请新用户注册赠送积分活动 2136123